Departamento de Ciencias Forenses, Anatomía Patolóxica, Xinecoloxía e Obstetricia e Pediatría
Fachbereich
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (83)
2024
-
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants
Journal of Infectious Diseases, Vol. 229, pp. S112-S119
-
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule
Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1
-
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
The Lancet Infectious Diseases
-
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
The Journal of experimental medicine, Vol. 221, Núm. 2
-
Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia
Genes and Diseases, Vol. 11, Núm. 3
-
Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain
Emerging Microbes and Infections
-
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453
-
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 161-170
-
Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study
Pediatric Allergy and Immunology, Vol. 35, Núm. 5
-
Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus
Nature Communications, Vol. 15, Núm. 1
2023
-
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)
Vaccine, Vol. 41, Núm. 21, pp. 3387-3398
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Addressing influenza’s underestimated burden – Iberian experts call to action
BMC Infectious Diseases
-
Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract
Journal of Infection, Vol. 87, Núm. 6, pp. 538-550
-
COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain
Pediatric Allergy and Immunology, Vol. 34, Núm. 10
-
Challenges and unmet needs in FPIES from the parents and adult patients’ perspective: An international survey
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 4, pp. 1306-1309.e2
-
Chatting with ChatGPT to learn about safety of COVID-19 vaccines–A perspective
Human Vaccines and Immunotherapeutics
-
Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015–2018
BMC Infectious Diseases, Vol. 23, Núm. 1